Bullboard - Stock Discussion Forum CytoDyn Inc CYDY

Healthcare Biotechnology

CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells. It has studied leronlimab in multiple therapeutic areas, including infectious... see more

Add To Watchlist

OTCQB:CYDY - Post Discussion

CytoDyn Inc > .

View:

Post by My19sixyNineZ on Mar 05, 2024 9:39am

.

Imagine finding a new drug candidate as a shareholder & not yet knowing how it will perform in even 1 dosing.

Unknown safety, cost, etc...etc.. It then blows the doors off many SOC's.

Holy grail of investing.

These advantages each of us have here, for having stayed connected.

Congratulations & may LL help many, on many continents.

It's time has come

Comment

Comment by Pandora on Mar 21, 2024 12:53am

CYDY has a new patent that is virtually approved -- that is, it has been given a Notice of Allowance by the USPTO which means they have to pay a fee and then wait for the approval of a new patent number to be posted. I would post this on the Yahoo board but for whatever reason I cannot access the board. 17/148,281 | 230042.431: METHOD OF TREATING METASTATIC TRIPLE NEGATIVE BREAST CANCER ...more

Comment

Comment by Pandora on Mar 21, 2024 12:57am

If anybody reading this patent stuff has access to the Yahoo board it might be helpful to copy and post over there.

Comment

Comment by Pandora on May 17, 2024 9:41pm

Presumably nobody on here has access to the Yahoo board. Oh well! Funny they have a virtual approval on their Patent - all they have to do is pay $480 but for some reason they do not appear to be doing that. They have to do that by May 21st and this is May 17??

Comment